000			02711nam a2200349 c 4500
999			_c7096 _d7096
001			7096
003			ES-MaUEC
005			20200706095534.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			190107s2019 si a o |||| 0|eng d
020			_a9789811055027
024	7		_a10.1007/978-981-10-5502-7 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280 _b.M35 2019 EB
245	0	0	_aManagement of Urothelial Carcinoma _cedited by Ja Hyeon Ku
264		1	_aSingapore _bSpringer Singapore : _bImprint: Springer _c2019.
300			_a1 recurso en línea (VI, 196 páginas 84 ilustraciones, 82 ilustraciones a color)
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF _2rda
490	0		_aMedicine (Springer-11650)
505	0		_aI. Urothelial carcinoma of the bladder -- 1. Diagnosis -- 2. Treatment of non-muscle invasive bladder cancer -- 3. Treatment of muscle invasive bladder cancer -- 4. Treatment of advanced or metastatic bladder cancer -- II. Upper tract urothelial carcinoma -- 1. Diagnosis -- 2. Nephron-sparing surgery -- 3. Nephroureterectomy -- 4. Treatment of advanced or metastatic UTUC.
520	3		_aThis book provides a comprehensive overview of contemporary evidence-based management of urothelial carcinoma. The first part of the book is devoted to urothelial carcinoma of the bladder and includes detailed description of the diagnosis and treatment of non-muscle-invasive, muscle-invasive, and advanced or metastatic disease. Attention then turns to upper tract urothelial carcinoma (UTUC), with individual chapters on diagnosis, nephron-sparing surgery, nephroureterectomy, and treatment of advanced or metastatic UTUC. The text is supported by many illustrations, photos, and tables that clarify management, and surgical video clips are also available to readers. The book will be a welcome addition to the literature as progress continues to be made in understanding the exact pathophysiology of urothelial carcinoma and in developing more effective diagnostic and therapeutic modalities. It will be useful both to researchers in the field of urothelial carcinoma and to clinicians, including especially residents and fellows.
988			_aPrimersemestre_2019_Medicine
650		7	_9667082 _aVejiga _xCáncer
710	2		_aSpringerLink (Online service) _9106937
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-5502-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db _feng _ggw _h0 _el _zSI